YCU-AML1 will be available to the research community upon request and we believe our model will serve as a valuable tool for future studies exploring pathogenesis of high-risk MDS/AML with t(3;3)(q21;q26.2) and monosomy 7. Here, RUNX1 is linked to acute myeloid leukemia.